日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

IGH::FENDRR and specific KRAS mutations define a novel B-ALL molecular subtype with poor chemotherapy response

IGH::FENDRR 和特定的 KRAS 突变定义了一种新型的 B 细胞急性淋巴细胞白血病 (B-ALL) 分子亚型,该亚型对化疗反应较差。

Bendig, Sonja; Hartmann, Alina M; Wessels, Wiebke; Beder, Thomas; Kim, Rathana; Passet, Marie; Gao, Qingsong; Wolgast, Nadine; Horns, Johanna M; Alves Santos, Leonardo; Iben, Katharina; Steffen, Fabio D; Cantoni, Loredana; Kehden, Britta; Chitadze, Guranda; Künstner, Axel; Busch, Hauke; Bornhauser, Beat; Bourquin, Jean-Pierre; Leguay, Thibaut Tl; Boissel, Nicolas; Gökbuget, Nicola; Iacobucci, Ilaria; Mullighan, Charles G; Clappier, Emmanuelle; Baldus, Claudia D; Brüggemann, Monika; Bastian, Lorenz

Intra-subtype heterogeneity shapes treatment response in KMT2A-rearranged ALL across all age groups

亚型内异质性影响所有年龄组中KMT2A重排ALL的治疗反应

Hartmann, Alina M; Bastian, Lorenz; Barz, Malwine J; Haas, Johannes; Amelunxen, Eric; Ehm, Patrick; Lenk, Lennart; Kotrova, Michaela; Beder, Thomas; Steffen, Fabio D; Rauwolf, Kerstin; Wolgast, Nadine; Bendig, Sonja; Bozzetti, Cecilia; Alten, Julia; Mondal, Mayukh; Rademacher, Annika; Heymann, Julia; Walter, Wencke; Haferlach, Claudia; Ströh, Aeint-Steffen; Bergmann, Anke K; Burmeister, Thomas; Gökbuget, Nicola; Bornhauser, Beat; Bourquin, Jean-Pierre; Brüggemann, Monika; Schrappe, Martin; Cario, Gunnar; Baldus, Claudia D

Toward chemotherapy-reduced cure for TCF3::HLF B-cell acute lymphoblastic leukemia using CD19-directed immunotherapy

利用CD19靶向免疫疗法减少TCF3::HLF B细胞急性淋巴细胞白血病的化疗治愈

Zeckanovic, Aida; Baruchel, André; Bourquin, Jean-Pierre

Functional precision approach in patients with very high risk acute lymphoblastic leukaemia in India: a single-centre cohort study

印度高危急性淋巴细胞白血病患者的功能精准治疗:一项单中心队列研究

Sidhu, Jasmeet; Chakraborty, Arijit; Das, Parag; Steffen, Fabio D; Kundu, Subhajit; Basu, Sangramjit; Tarafdar, Bhaswati; Dey, Tanima; Kar, Abhirupa; Biswas, Mousumi; Das, Ankita; Sivadasan, Naveen; Dasgupta, Pritha; Ghara, Niharendu; Bornhauser, Beat; Bourquin, Jean-Pierre; Krishnan, Shekhar; Saha, Vaskar

Systematic review of hematopoietic stem cell transplantation in patients with ataxia telangiectasia: a case report and an individual patient-level analysis

对毛细血管扩张性共济失调患者进行造血干细胞移植的系统评价:病例报告和个体患者水平分析

Bekis Bozkurt, Hayrunnisa; Spaccamela, Virginia Meda; Hassan, Moustapha; Felber, Matthias; Zeilhofer, Ulrike; Zeckanovic, Aida; Bourquin, Jean-Pierre; Jacquier, David; Ceppi, Francesco; Candotti, Fabio; Güngör, Tayfun

Multinational retrospective analysis of bridging therapy prior to chimeric antigen receptor t cells for relapsed/refractory acute lymphoblastic leukemia in children and young adults

一项针对儿童和青少年复发/难治性急性淋巴细胞白血病嵌合抗原受体T细胞治疗前桥接治疗的多国回顾性分析

Breidenbach, Maike; Bader, Peter; Attarbaschi, Andishe; Rossig, Claudia; Meisel, Roland; Metzler, Markus; Subklewe, Marion; Mueller, Fabian; Schlegel, Paul-Gerhardt; Teichert von Lüttichau, Irene; Bourquin, Jean-Pierre; Escherich, Gabriele; Cario, Gunnar; Lang, Peter; Coffey, Ramona; von Stackelberg, Arend; Willier, Semjon; Strahm, Brigitte; Peters, Christina; Feuchtinger, Tobias

Transcriptional remodeling shapes therapeutic vulnerability to necroptosis in acute lymphoblastic leukemia.

转录重塑影响急性淋巴细胞白血病细胞对坏死性凋亡的治疗敏感性。

Saorin Anna, Dehler Anna, Galvan Bartimée, Steffen Fabio, Ray Marine, Lu Dong, Yu Xin, Kim James, Drakul Aneta, Kisele Samanta, Wang Jin, Bourquin Jean-Pierre, Bornhauser Beat C

Patient-derived tumoroids from CIC::DUX4 rearranged sarcoma identify MCL1 as a therapeutic target.

从 CIC::DUX4 重排肉瘤中分离出的患者来源的肿瘤样细胞确定 MCL1 为治疗靶点

Breunis Willemijn, Brack Eva, Ehlers Anna C, Bechtold Ingrid, Kisele Samanta, Wurth Jakob, Mous Lieke, Zabele Dorita, Steffen Fabio, Zahnow Felina, Britschgi Christian, Bankel Lorenz, Rothermundt Christian, Vetter Cornelia, Müller Daniel, Botter Sander, Pauli Chantal, Bode Peter, Rinner Beate, Bourquin Jean-Pierre, Roessler Jochen, Grünewald Thomas G P, Schäfer Beat W, Surdez Didier, Wachtel Marco

Results in pediatric T-ALL patients treated in trial AIEOP-BFM ALL 2009: Prognostic factors in the context of modern risk-adapted therapy

AIEOP-BFM ALL 2009 试验中接受治疗的儿童 T 细胞急性淋巴细胞白血病 (T-ALL) 患者的结果:现代风险适应性治疗背景下的预后因素

Cario, Gunnar; Valsecchi, Maria Grazia; Conter, Valentino; Gotti, Giacomo; Möricke, Anja; Stanulla, Martin; Vossen-Gajcy, Michaela; Lenk, Lennart; Stary, Jan; Hrusak, Ondrej; Dworzak, Michael; Attarbaschi, Andishe; Barbaric, Draga; Locatelli, Franco; Bodmer, Nicole; Elitzur, Sarah; Silvestri, Daniela; Dalla-Pozza, Luciano; Fagioli, Franca; Kulozik, Andreas E; Izraeli, Shai; Rizzari, Carmelo; Rademacher, Annika; Buldini, Barbara; Bourquin, Jean-Pierre; Zimmermann, Martin; Schrappe, Martin; Biondi, Andrea

Prognostic relevance of treatment deviations in children with relapsed acute lymphoblastic leukemia who were treated in the ALL-REZ BFM 2002 study

ALL-REZ BFM 2002 研究中治疗方案偏差对复发性急性淋巴细胞白血病患儿预后意义

Argyriadi, Eleni A; Steffen, Ingo G; Chen-Santel, Christiane; Lissat, Andrej; Attarbaschi, Andishe; Bourquin, Jean-Pierre; Henze, Guenter; von Stackelberg, Arend